BioShanghai Week 2026 will run from Sept 17 to 20 in Shanghai, bringing together industry leaders, Nobel laureates, and investors to advance life sciences collaboration.

Now in its sixth edition, the conference will draw major multinational pharmaceutical companies including Sanofi, Novartis, Roche, and AstraZeneca, alongside leading domestic giants such as Shanghai Pharma, United Imaging, and Fosun Pharma. Attendees will also include leaders in international regulatory and accreditation bodies.

The conference is organized around five core themes: innovation integration, clinical translation, capital empowerment, ecosystem services, and coordinated healthcare development. Specialized tracks will cover cutting-edge fields such as cell and gene therapy, Parkinson's disease treatments, novel immunotherapies, AI-enabled drug discovery, brain-computer interfaces, and smart elderly care.

Global partnership remains a central focus, with country-specific forums highlighting key markets across the United States, the United Kingdom, Ireland, Australia, and Southeast Asia.

The event also offers immersive tour programs, providing international delegates with firsthand exposure to Shanghai's life sciences hub through guided visits to leading enterprises, university laboratories, and clinical research centers.

This year's summit comes amid a surge in Chinese pharmaceutical innovation. In the first half of 2026 alone, China's outbound licensing deals totaled $99.7 billion, more than double the total volume recorded in all of 2024 and representing 73 percent of 2025's full-year volume.

Investment and dealmaking will take center stage throughout the conference. Roadshow tracks will showcase ventures in gene and cell therapy, medical devices, digital health, and innovative therapeutics, creating pathways for domestic and international projects to connect with capital.

The inaugural Jefferies Asia Pacific healthcare conference will run concurrently, aligning with companies' international financing and partnership needs. A dedicated appointment platform will help participants identify potential partners and schedule negotiations, designed to accelerate progress from initial introductions to signed agreements.

Source: China Daily